Gerresheimer reports lower half-year core profit
Gerresheimer reports lower half-year core profit Sept 30 (Reuters) - Drug-packaging maker Gerresheimer GXIG.DE reported a lower core profit for the first half of 2026 on Wednesday, as weakness in its Moulded Glass business and lower demand for injection vials weighed on performance.
The German company reported preliminary half-year earnings before interest, taxes, depreciation and amortisation of €168 million ($191 million), compared with €210.4 million a year ago.
($1 = 0.8811 euros)
(Reporting by Kira Britten and Danny Callaghan in Gdansk, editing by Milla Nissi-Prussak)
Recent news on Gerresheimer AG
See all newsGermany's Gerresheimer prelim Q3 revenue rises on strong demand for drug delivery devices
Brief: Gerresheimer Reports Q3 Revenue Of EUR 605 Mln
Brief: Gerresheimer Completes Sale Of Centor
Brief: Gerresheimer Targets Leverage At Or Below 3x Net Debt To Ebitda
Gerresheimer gains as Q2 shows quarter-on-quarter recovery